Abstract
BackgroundCanine models of Duchenne muscular dystrophy (DMD) are a valuable tool to evaluate potential therapies because they faithfully reproduce the human disease. Several cases of dystrophinopathies have been described in canines, but the Golden Retriever muscular dystrophy (GRMD) model remains the most used in preclinical studies. Here, we report a new spontaneous dystrophinopathy in a Labrador Retriever strain, named Labrador Retriever muscular dystrophy (LRMD).MethodsA colony of LRMD dogs was established from spontaneous cases. Fourteen LRMD dogs were followed-up and compared to the GRMD standard using several functional tests. The disease causing mutation was studied by several molecular techniques and identified using RNA-sequencing.ResultsThe main clinical features of the GRMD disease were found in LRMD dogs; the functional tests provided data roughly overlapping with those measured in GRMD dogs, with similar inter-individual heterogeneity. The LRMD causal mutation was shown to be a 2.2-Mb inversion disrupting the DMD gene within intron 20 and involving the TMEM47 gene. In skeletal muscle, the Dp71 isoform was ectopically expressed, probably as a consequence of the mutation. We found no evidence of polymorphism in either of the two described modifier genes LTBP4 and Jagged1. No differences were found in Pitpna mRNA expression levels that would explain the inter-individual variability.ConclusionsThis study provides a full comparative description of a new spontaneous canine model of dystrophinopathy, found to be phenotypically equivalent to the GRMD model. We report a novel large DNA mutation within the DMD gene and provide evidence that LRMD is a relevant model to pinpoint additional DMD modifier genes.
Highlights
Canine models of Duchenne muscular dystrophy (DMD) are a valuable tool to evaluate potential therapies because they faithfully reproduce the human disease
Biopsies from the biceps femoris muscle were sampled from both dogs and histological analysis revealed lesions of active necrosis, Fig. 1 Findings it the first cases point out a potential dystrophinopathy. a Pictures of the two first affected brothers (LRMD1 and 2), at 4 months of age, at time of their presentation to the neurology consultation of the Alfort school of veterinary medicine
The results showed that the sequence of this promoter was identical in all the Labrador Retriever muscular dystrophy (LRMD) dogs tested and that none of these dogs harboured the G>T point mutation described in Golden Retriever muscular dystrophy (GRMD) escapers
Summary
Canine models of Duchenne muscular dystrophy (DMD) are a valuable tool to evaluate potential therapies because they faithfully reproduce the human disease. Several cases of dystrophinopathies have been described in canines, but the Golden Retriever muscular dystrophy (GRMD) model remains the most used in preclinical studies. Duchenne muscular dystrophy (DMD) is an X-linked inherited disorder due to mutations in the Dystrophin gene. Thereafter, the disease progresses rapidly and leads to a permanent use of the wheelchair at a mean age of 10 years without steroid therapy [3]. Despite the significant progress in the medical management of these patients made over the last decades, respiratory and cardiac insufficiencies lead to premature death of these patients in the third to fourth decade of life (median 29.9 years in a recently published meta-analysis study) [4]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.